Drug Approval | September 25, 2023
Strides receives USFDA approval for Icosapent Ethyl Capsules
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Clindamycin Phosphate Gel is used to treat acne
InvaGen has received 5 inspectional observations in Form 483
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Subscribe To Our Newsletter & Stay Updated
